Connecticut Innovations (CI), the state’s quasi-public venture capital arm based in New Haven, said Monday it invested approximately $11.3 million in 25 companies and venture funds during the first quarter of its fiscal year, which ended on Sept. 30.
CI said its investments leveraged $86.9 million in outside capital and generated $7 million in proceeds during the quarter.
More than half of the money invested during the quarter, about $6.9 million, was in the healthcare sector. Another $2.2 million was invested in venture funds, while about $1.5 million was invested in climate tech companies, the organization said.
The remaining investments were in consumer and technology companies.
Matt Storeygard, senior managing director of investments, noted that CI recently launched a new $50 million AI and quantum technologies fund, which made its first $2 million investment in Bexorg announced last month.
Bexorg, based at 290 Congress Ave. in New Haven, is advancing central nervous system drug discovery with its technology platform BrainEx, which restores certain molecular functions in postmortem human brains, creating a model that closely mirrors how drugs might act in living tissue.